check quantity

ViewPlate-96 Black, Glass Bottom, Tissue Culture Treated, Sterile, 96-Well with Lid, Case of 40

96-well tissue culture treated (TC-treated) sterile ViewPlate microplate with glass clear bottom and black well walls for high content analysis applications.

Part Number
List Price
Your Price
2096.00 USD
Buy Now

Please enter valid quantity

Please log in to add favorites.



Our ViewPlate microplates are engineered for bottom reading systems and high content imaging. Glass exhibits better optical properties and is perfectly flat, but is less-suited for cell culture. Glass therefore usually has to be coated with proteins that enhance cell adherence and growth (e.g., poly-D-lysine or collagen). This high quality microplate can be utilized in your cell based assay for superior results.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.

Packaging Notes:

  • Cases of 40 glass-bottom 96-well plates are packaged as 40 individually bagged and sealed lidded plates.

Well Plate Dimensions

Well format: 96-well w/Glass bottom

Description Specification
Number of Rows 8
Number of Columns 12
Well volume 300 µL
Recommended working volume 50 µL- 200 µL
Height (mm) 11.6
Length (mm) 127.75
Width (mm) 85.34
Well diameter (mm) 6
Well depth (mm) 11.35
A1 to top offset (mm) 11.3
A1 to side offset (mm) 14.3
Well-to-well spacing (mm) 9


Automation Compatible Yes
Coating Treatment TC-treated, Sterile
Color Black/Clear Bottom
Detection Method Confocal Imaging, Fluorescence, High Content Imaging
Material Polystyrene, Glass Bottom
Product Brand Name ViewPlate
Sterile Yes
Unit Size Case of 40
Wells Number 96 well plate
Resources, Events & More
  • All


Drug Discovery Screening Solutions Brochure

Find out about our range of integrated solutions for drug discovery screening in this e-brochure.

Our screening solutions for high-throughput screening, phenotypic screening and data analysis help to streamline drug discovery workflows in labs across the globe. Our portfolio includes automated liquid handling, assays and reagents, imaging and detection systems, and informatics.

Working independently or together, with our solutions you can achieve consistent and accurate results. By accelerating the identification and characterization of effective and safe drug candidates, the PerkinElmer portfolio enables you to optimize efficiency in your lab and deliver more actionable, real-world results.

Download the brochure to learn more about how we can partner with you so that you can discover smarter, more effective, data-driven breakthroughs in the critical screening stages of drug discovery and development.